Longevity Acquisition Common Stock

Longevity Acquisition (LOAC) currently reports a common stock of $40M as of May 2020. That compares with $40M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Longevity Acquisition's common stock history and peer comparisons.

Longevity Acquisition's common stock was unchanged from $40M to $40M — essentially flat versus a year earlier (period ending May 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Longevity Acquisition reported $40M in common stock as of May 2020. That compares with $40M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $40M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Longevity Acquisition, and consider following LOAC for alerts when major investors trade the stock.